Uromigos-Paper of the Month

The UromigosThe Uromigos | September 14, 2023
Dr. Susan F. Slovin discusses her recent paper that examined abiraterone with and without cabazitaxel for mCRPC.
Listen Now
The UromigosThe Uromigos | May 9, 2022
Syed Hussain and Sam Funt describe their studies on this topic.
The UromigosThe Uromigos | April 6, 2022
Martin Stockler describes the ENZAMET trial, which shows mixed effects of enza on QOL in prostate cancer.
The UromigosThe Uromigos | April 1, 2022
Yelena Janjigian describes ipi/nivo versus nivo chemo versus chemo in gastric cancer.
The UromigosThe Uromigos | February 7, 2022
Elizabeth de Vries describes her paper on this topic published in Annals of Oncology.
The UromigosThe Uromigos | December 21, 2021
Chad Tang discusses his oncology paper recently published in Lancet.
The UromigosThe Uromigos | November 17, 2021
Dr. Samra Turajlic describes her paper on clear cell renal cell carcinoma.
The UromigosThe Uromigos | October 29, 2021
Dr. Mike Atkins discusses the role of CTLA4 inhibition in RCC.
The UromigosThe Uromigos | October 27, 2021
Dr. Tanya Dorff discusses the TALAPRO-1 study and the role of PARP inhibitors in prostate cancer.
The UromigosThe Uromigos | August 27, 2021
Martin Eklund discusses his papers published in the New England Journal of Medicine and Lancet Oncology.
The UromigosThe Uromigos | May 26, 2021
Dr. Eric Jonasch gives an overview of his paper published in Nature Medicine.
The UromigosThe Uromigos | May 4, 2021
Dr. Petros Grivas discusses the accelerated approval of sacituzumab govitecan in bladder cancer.
The UromigosThe Uromigos | April 14, 2021
Silke Gillessen discusses the back-to-back JCO papers on risk classification for germ cell cancer.
The UromigosThe Uromigos | March 26, 2021
Dr. Joaquim Bellmunt describes this study, as well as adjuvant nivolumab and ctDNA in bladder cancer.
The UromigosThe Uromigos | March 4, 2021
David McDermott describes back-to-back publications that examine pembrolizumab in clear cell and non-clear cell renal cancer.
The UromigosThe Uromigos | February 6, 2021
Dr. Stephen Boorjian outlines his non-muscle invasive bladder cancer paper published in Lancet.
The UromigosThe Uromigos | December 8, 2020
Dr. Kim Rathmell discusses this paper, which divides clear cell renal cancer into seven relevant subgroups.
The UromigosThe Uromigos | November 9, 2020
Drs. Pam Sharma and Michiel Van Der Heijden discuss neoadjuvant PD(L)1 + CTLA4 inhibition in urothelial cancer.
The UromigosThe Uromigos | October 6, 2020
Dr. James Eastham describes this study, which gives insight into perioperative treatments for high-risk prostate cancer.
The UromigosThe Uromigos | August 31, 2020
Dr. Andrea Apolo talks about her phase 2 trial which shows activity for Cabozantinib in urothelial cancer.
Advertisement
Advertisement